178 related articles for article (PubMed ID: 35882956)
1. TRPM7 deficiency exacerbates cardiovascular and renal damage induced by aldosterone-salt.
Rios FJ; Zou ZG; Harvey AP; Harvey KY; Camargo LL; Neves KB; Nichol SEF; Alves-Lopes R; Cheah A; Zahraa M; Ryazanov AG; Ryazanova L; Gudermann T; Chubanov V; Montezano AC; Touyz RM
Commun Biol; 2022 Jul; 5(1):746. PubMed ID: 35882956
[TBL] [Abstract][Full Text] [Related]
2. Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis.
Rios FJ; Zou ZG; Harvey AP; Harvey KY; Nosalski R; Anyfanti P; Camargo LL; Lacchini S; Ryazanov AG; Ryazanova L; McGrath S; Guzik TJ; Goodyear CS; Montezano AC; Touyz RM
Cardiovasc Res; 2020 Mar; 116(3):721-735. PubMed ID: 31250885
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium.
Sontia B; Montezano AC; Paravicini T; Tabet F; Touyz RM
Hypertension; 2008 Apr; 51(4):915-21. PubMed ID: 18268139
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone signaling through transient receptor potential melastatin 7 cation channel (TRPM7) and its α-kinase domain.
Yogi A; Callera GE; O'Connor S; Antunes TT; Valinsky W; Miquel P; Montezano AC; Perraud AL; Schmitz C; Shrier A; Touyz RM
Cell Signal; 2013 Nov; 25(11):2163-75. PubMed ID: 23838006
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of renal transient receptor potential melastatin 6/7 but not paracellin-1 in aldosterone-induced hypertension and kidney damage in a model of hereditary hypomagnesemia.
Yogi A; Callera GE; O'Connor SE; He Y; Correa JW; Tostes RC; Mazur A; Touyz RM
J Hypertens; 2011 Jul; 29(7):1400-10. PubMed ID: 21602712
[TBL] [Abstract][Full Text] [Related]
6. Transient Receptor Potential Melastatin 7 Cation Channel Kinase: New Player in Angiotensin II-Induced Hypertension.
Antunes TT; Callera GE; He Y; Yogi A; Ryazanov AG; Ryazanova LV; Zhai A; Stewart DJ; Shrier A; Touyz RM
Hypertension; 2016 Apr; 67(4):763-73. PubMed ID: 26928801
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor signaling through transient receptor potential melastatin 7 cation channel regulates vascular smooth muscle cell function.
Zou ZG; Rios FJ; Neves KB; Alves-Lopes R; Ling J; Baillie GS; Gao X; Fuller W; Camargo LL; Gudermann T; Chubanov V; Montezano AC; Touyz RM
Clin Sci (Lond); 2020 Aug; 134(15):2019-2035. PubMed ID: 32706027
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia.
Paravicini TM; Yogi A; Mazur A; Touyz RM
Hypertension; 2009 Feb; 53(2):423-9. PubMed ID: 19103997
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse.
Waeckel L; Potier L; Chollet C; Taveau C; Bruneval P; Roussel R; Alhenc-Gelas F; Bouby N
Endocrinology; 2012 Aug; 153(8):3886-96. PubMed ID: 22669897
[TBL] [Abstract][Full Text] [Related]
10. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II.
He Y; Yao G; Savoia C; Touyz RM
Circ Res; 2005 Feb; 96(2):207-15. PubMed ID: 15591230
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair.
Samarakoon R; Rehfuss A; Khakoo NS; Falke LL; Dobberfuhl AD; Helo S; Overstreet JM; Goldschmeding R; Higgins PJ
FASEB J; 2016 Oct; 30(10):3308-3320. PubMed ID: 27328942
[TBL] [Abstract][Full Text] [Related]
12. TRPM6 kinase activity regulates TRPM7 trafficking and inhibits cellular growth under hypomagnesic conditions.
Brandao K; Deason-Towne F; Zhao X; Perraud AL; Schmitz C
Cell Mol Life Sci; 2014 Dec; 71(24):4853-67. PubMed ID: 24858416
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction.
Syed M; Ball JP; Mathis KW; Hall ME; Ryan MJ; Rothenberg ME; Yanes Cardozo LL; Romero DG
Am J Physiol Endocrinol Metab; 2018 Dec; 315(6):E1154-E1167. PubMed ID: 30153065
[TBL] [Abstract][Full Text] [Related]
14. TRPM7 in CHBP-induced renoprotection upon ischemia reperfusion-related injury.
Liu A; Wu J; Yang C; Wu Y; Zhang Y; Zhao F; Wang H; Yuan L; Song L; Zhu T; Fan Y; Yang B
Sci Rep; 2018 Apr; 8(1):5510. PubMed ID: 29615639
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone+salt-induced cardiac fibrosis in vivo.
Mummidi S; Das NA; Carpenter AJ; Kandikattu H; Krenz M; Siebenlist U; Valente AJ; Chandrasekar B
J Mol Cell Cardiol; 2016 Sep; 98():95-102. PubMed ID: 27423273
[TBL] [Abstract][Full Text] [Related]
16. TRPM7 is involved in angiotensin II induced cardiac fibrosis development by mediating calcium and magnesium influx.
Yu Y; Chen S; Xiao C; Jia Y; Guo J; Jiang J; Liu P
Cell Calcium; 2014 May; 55(5):252-60. PubMed ID: 24680379
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the role of the TRPM7 alpha-kinase: TRPM7 kinase inactivation leads to magnesium deprivation resistance phenotype in mice.
Ryazanova LV; Hu Z; Suzuki S; Chubanov V; Fleig A; Ryazanov AG
Sci Rep; 2014 Dec; 4():7599. PubMed ID: 25534891
[TBL] [Abstract][Full Text] [Related]
18. TRPM7: a unique channel involved in magnesium homeostasis.
Paravicini TM; Chubanov V; Gudermann T
Int J Biochem Cell Biol; 2012 Aug; 44(8):1381-4. PubMed ID: 22634382
[TBL] [Abstract][Full Text] [Related]
19. Transient receptor potential melastatin 7 (TRPM7) contributes to H2O2-induced cardiac fibrosis via mediating Ca(2+) influx and extracellular signal-regulated kinase 1/2 (ERK1/2) activation in cardiac fibroblasts.
Guo JL; Yu Y; Jia YY; Ma YZ; Zhang BY; Liu PQ; Chen SR; Jiang JM
J Pharmacol Sci; 2014; 125(2):184-92. PubMed ID: 24871786
[TBL] [Abstract][Full Text] [Related]
20. Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7.
Chubanov V; Mederos y Schnitzler M; Meißner M; Schäfer S; Abstiens K; Hofmann T; Gudermann T
Br J Pharmacol; 2012 Jun; 166(4):1357-76. PubMed ID: 22242975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
